Covaxin efficacy rate

Bharat Biotech’s Covaxin Shows 77.8 Percent Efficacy In Phase 3 Trial

The Covaxin Phase 3 trial has shown a result of 77.8 percent efficacy according to new reports. Covaxin is one of the three COVID vaccines currently approved and used in India.